Nuvation Bio Inc.
NUVB
$8.17
$0.709.30%
NYSE
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/3/2025
-
Nasdaq News: Markets
12/3/2025
-
Tickeron - Stocks
12/3/2025
-
SeekingAlpha
12/3/2025
-
Seeking Alpha: Transcripts
12/3/2025
-
TipRanks Financial Blog
12/3/2025
-
The Fly
12/3/2025
-
GuruFocus
12/3/2025
-
GuruFocus
12/3/2025
-
The Fly
12/3/2025
-
Business Wire
12/3/2025
-
MarketBeat
12/2/2025
-
Simply Wall St
12/1/2025
-
MarketBeat
11/30/2025
-
TipRanks Financial Blog
11/29/2025
-
Seeking Alpha - Long Ideas
11/29/2025
-
SeekingAlpha
11/28/2025
-
Simply Wall St
11/28/2025
-
MarketBeat
11/27/2025
-
MarketBeat
11/27/2025
-
Ticker Report
11/26/2025
-
GuruFocus
11/26/2025
-
Business Wire
11/26/2025
-
GuruFocus
11/26/2025
-
GuruFocus
11/26/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, November 3, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 2 and 6 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
332 208 6102
Address
1500 Broadway
New York, NY 10036
New York, NY 10036
Country
Year Founded
Business Description
Sector
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology. Its lead product candidate is taletrectinib, an ROS1 inhibitor for the...
more